Bayer
CropScience Limited
Unuadited
Financial Results for the Quarter ended 31st March, 2007 |
Rs. in Lacs |
| |
Quarter Ended |
Year Ended |
Particulars |
31st
March,2007 |
31st
March,2006 |
31st
December 2006
(Audited) |
| Sales and Other Operating Income |
13,875 |
10,538 |
77,574 |
| Other Income |
328 |
422 |
3,273 |
| Total Income |
14,203 |
10.960 |
80,847 |
| Expenditure |
- |
| (a) (Increase)/Decrease in Stock |
(2,364) |
(477) |
(218) |
| (b) Consumption of Raw Materials |
7,394 |
5,976 |
31,119 |
| (c) Cost of Traded Goods sold |
2,995 |
192 |
14,153 |
| (d) Staff Cost |
1,975 |
1,505 |
6,739 |
| (e) Other Expenditure |
3,890 |
3,404 |
16,505 |
Total
Expenditure |
13,890 |
10,600 |
68,298 |
| Interest |
114 |
153 |
733 |
| Depreciation / Amortisation |
514 |
531 |
2,186 |
| Impairment Loss on Fixed Assets |
- |
- |
683 |
PROFIT / (LOSS) FOR
THE PERIOD BEFORE EXCEPTIONAL ITEMS AND TAXATION
|
(315)
|
(324) |
8,947 |
Less: Exceptional Items (Voluntary Retirement Expenditure)
|
- |
-
|
(42)
|
PROFIT / (LOSS) FOR THE PERIOD
BEFORE TAXATION
|
(315)
|
(324) |
8,905 |
Less: Provision For Taxation
(including Deferred Tax & Fringe Benefit Tax)
|
53
|
53 |
(3,220) |
PROFIT/ (LOSS) FOR THE PERIOD AFTER TAXATION
|
(262)
|
(271) |
5,685 |
Paid up Equity Share Capital
(Face Value Rs. 10)
|
3,950
|
3,950
|
3,950
|
Reserves and Surplus(excluding Revaluation Reserve)
|
- |
- |
29,193
|
Number of Equity Shares
(Face Value Rs. 10)
|
39,498,747
|
39,498,747
|
39,498,747
|
-
|
- |
- |
- |
Earning Per Share (basic & diluted)
[excluding exceptional items (net of tax)]
|
(0.66)
|
(0.68) |
14.47 |
Earning Per Share (basic & diluted)
[including exceptional items (net of tax)]
|
(0.66) |
(0.68) |
14.39 |
Aggregate of non-promoters shareholdings
|
|
|
|
Number of shares
|
11,412,085
|
11,412,085 |
11,412,085 |
Percentage of shareholding (%)
|
28.89%
|
28.89%
|
28.89%
|
Notes:
1. The above results have been reviewed and recommended
by the Audit Committee and approved by the Board of Directors of the
Company at its meeting held on 16th April, 2007 and the statutory auditors
have carried out a limited review of the results for the period ended
31st March, 2007.
2. The Board of Directors of the Company at its meeting held on 26th
March, 2007 has considered the proposal for sale of equity shares (costing
Rs. 5 lacs) in Bayer Polychem (India) Limited, its wholly owned subsidiary,
to Bayer MaterialScience Private Limited at a consideration of Rs. 390
lacs based on valuation carried out by an independent valuer and is
subject to necessary approvals.
3. IIn accordance with the past practice consistently followed, Sales
for the three months ended 31st March, 2007 are net of estimated returns
of Rs.763 lacs (Jan - Mar 2006: Rs. 599 lacs), in respect of seasonal
sales which in Management's opinion, may need to be reviewed dependant
on future circumstances. Further, sales returns are accounted at actuals
at the year end.
4. In view of Accounting Standard - 15 (Revised)
on 'Employee Benefits' becoming applicable from accounting periods beginning
7th December, 2006, an additional provision of Rs. 88 lacs has been
made towards compensated absences during quarter ended 31st March, 2007.
Further, there is no change in liability towards retirement benefits
as at 1st January, 2007.
5. The Company has only one reportable business segment, i.e. “Agri
Care ”.
6 . The status of Investor complaints received and disposed off during
the quarter ended 31st March, 2007 is:
| Complaints pending at the beginning of the quarter |
0 |
| Complaints received during the quarter |
2 |
| Complaints attended during the quarter |
2 |
| Complaints lying unresolved at the end of the quarter |
0 |
7. Previous period’s figures have been regrouped wherever necessary.
|
Place: Mumbai
Date : 16th April, 2007
|
By Order of the Board
sd/-
Christiane Kunze
Director |
|
